FGF23 and chronic kidney disease: It is hypothesized that during chronic renal failure, the abnormally high expression of FGF23 activates the downstream signaling pathway and increases the conversion of D-serine through the serine shuttle, which overactivates the NMDAR of the auditory nerve and increases excitatory neurotoxicity, leading to auditory damage.